Login / Signup
Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors.
Michael Patrick Bancks
Published in:
Diabetes care (2023)
Keyphrases
</>